{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04547166: Phase 2/Phase 3 Interventional Recruiting Metastatic Colorectal Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04123379: Phase 2 Interventional Active, not recruiting Non-small Cell Lung Cancer
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03494231: Phase 1 Interventional Terminated Solid Tumor, Adult
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:luveltamab tazevibulin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:nanrilkefusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:eftansomatropin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:acazicolcept [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN